Immune-supportive Diet and Gut Permeability in Allergic Children (DIAMETER)
Peanut Allergy, Nut Allergy
About this trial
This is an interventional treatment trial for Peanut Allergy focused on measuring Gut permeability, Immune-supportive diet, Thresholds
Eligibility Criteria
Inclusion Criteria: Children of 4 to 12 years of age with a positive open or double-blind placebo-controlled peanut or nut challenge < 12 months to inclusion; Children who are potty trained or house trained; Presence of IgE to peanut ≥0.35 kilo units per liter (kU/l) or skin prick test > 3 mm to peanut or nut, < 12 months prior to challenge. Exclusion Criteria: Only mild symptoms in the oral cavity to peanut or nut due to pollen food syndrome; A negative peanut or nut challenge; Children who are not potty trained (house trained); Gastro-intestinal diseases (e.g. Morbus Crohn, coeliac disease, Colitis Ulcerosa), syndromes, infectious/immunology diseases other than atopy, or diabetes; Laxative treatment, such as lactulose; Not able to read or write Dutch.
Sites / Locations
- OLVGRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention group (immune-supportive diet)
Control group
Immune-supportive diet (for 4 months) on top of peanut and/or nut free diet Feasibility of adherence to the Immune-supportive diet (intervention group only) and dietary compliance by Likert scale after 2,5 and 4 months of dietary intervention (2x)
- Peanut and/or nut free diet only